Stock Analysis
- Germany
- /
- Medical Equipment
- /
- XTRA:SBS
June 2024 Insight Into German Growth Companies With High Insider Ownership
Reviewed by Simply Wall St
Amidst a week of political uncertainties and mixed economic signals across Europe, the German market has mirrored this volatility with significant index fluctuations. In such an environment, discerning investors often look toward growth companies with high insider ownership as these firms tend to exhibit resilience and a deep alignment of interests between shareholders and management.
Top 10 Growth Companies With High Insider Ownership In Germany
Name | Insider Ownership | Earnings Growth |
pferdewetten.de (XTRA:EMH) | 26.8% | 75.4% |
Deutsche Beteiligungs (XTRA:DBAN) | 35.4% | 31.6% |
YOC (XTRA:YOC) | 24.8% | 22.2% |
Exasol (XTRA:EXL) | 25.3% | 107.4% |
NAGA Group (XTRA:N4G) | 14.1% | 58.1% |
Alelion Energy Systems (DB:2FZ) | 37.4% | 106.6% |
Stratec (XTRA:SBS) | 30.9% | 22% |
elumeo (XTRA:ELB) | 25.8% | 99.1% |
Your Family Entertainment (DB:RTV) | 17.5% | 116.8% |
Friedrich Vorwerk Group (XTRA:VH2) | 18% | 30.4% |
Let's take a closer look at a couple of our picks from the screened companies.
Brockhaus Technologies (XTRA:BKHT)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Brockhaus Technologies AG operates as a private equity firm with a market capitalization of approximately €329.10 million.
Operations: The firm's revenue is primarily generated from its Financial Technologies segment, which brought in €153.43 million, and its Security Technologies segment, contributing €39.43 million.
Insider Ownership: 26.6%
Earnings Growth Forecast: 74.2% p.a.
Brockhaus Technologies AG, a growth-oriented company in Germany with significant insider ownership, is expected to become profitable within the next three years. Despite recent financial struggles including a net loss increase in the latest annual report, it forecasts robust revenue growth between 18% and 29% for 2024. The firm's strategic share buyback and its inaugural dividend proposal underscore a commitment to shareholder value amidst its ambitious growth targets.
- Navigate through the intricacies of Brockhaus Technologies with our comprehensive analyst estimates report here.
- Upon reviewing our latest valuation report, Brockhaus Technologies' share price might be too pessimistic.
Deutsche Beteiligungs (XTRA:DBAN)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Deutsche Beteiligungs AG is a private equity and venture capital firm focusing on direct and fund of fund investments, with a market capitalization of approximately €516.65 million.
Operations: The company generates revenue primarily through Fund Investment Services and Private Equity Investments, totaling €47.85 million and €55.15 million respectively.
Insider Ownership: 35.4%
Earnings Growth Forecast: 31.6% p.a.
Deutsche Beteiligungs AG, amidst a challenging fiscal period with revenue dropping to €49.98 million from €103.33 million year-over-year, has initiated a substantial share repurchase program valued at €25 million, signaling confidence by the management. Despite recent earnings decline to €24.6 million from €82.59 million, analysts are optimistic, projecting significant stock price and earnings growth above market trends due to robust forecasted annual profit and revenue increases of 31.56% and 24.7% respectively.
- Take a closer look at Deutsche Beteiligungs' potential here in our earnings growth report.
- The valuation report we've compiled suggests that Deutsche Beteiligungs' current price could be quite moderate.
Stratec (XTRA:SBS)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Stratec SE operates in Germany and internationally, designing and manufacturing automation and instrumentation solutions for in-vitro diagnostics and life sciences, with a market capitalization of approximately €571.33 million.
Operations: The company generates its revenue by designing and manufacturing solutions for in-vitro diagnostics and life sciences across Germany, the European Union, and other global markets.
Insider Ownership: 30.9%
Earnings Growth Forecast: 22% p.a.
Stratec SE, despite a recent downturn in earnings with net income dropping to €0.447 million from €1.37 million Q1 year-over-year, remains a focus for growth-oriented investors due to its substantial insider ownership and a projected annual earnings growth of 22%. The company's revenue forecasts also outpace the German market average, although current profit margins have decreased. Recent presentations at major conferences underscore management's efforts to communicate strategy amidst these financial shifts.
- Delve into the full analysis future growth report here for a deeper understanding of Stratec.
- Upon reviewing our latest valuation report, Stratec's share price might be too optimistic.
Key Takeaways
- Access the full spectrum of 18 Fast Growing German Companies With High Insider Ownership by clicking on this link.
- Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
- Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.
Interested In Other Possibilities?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're helping make it simple.
Find out whether Stratec is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About XTRA:SBS
Stratec
Designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally.
Reasonable growth potential with mediocre balance sheet.